August 2026
Added to Dediabetes Aug 29, 2026RCTs
This pilot randomized controlled trial evaluated a holistic digital intervention aimed at improving lifestyle behaviors among Asian women with a history of gestational diabetes mellitus. The results indicated no statistically significant changes in key health outcomes.
Interventions
Holistic digital intervention
Outcomes
BMIBlood glucoseChange in WHO-5 Well-Being Index score+5 more
Added to Dediabetes Aug 29, 2026RCTs
This study examined the impact of lifestyle interventions on postpartum diabetes risk in women with prior gestational diabetes, finding a significant reduction in diabetes incidence among those who underwent intensive lifestyle changes.
Interventions
Lifestyle intervention for prediabetesUsual care
Outcomes
BMIBody fat percentage reductionBody weight+2 more
Added to Dediabetes Aug 29, 2026RCTs
This study investigated the long-term effects of a lifestyle intervention on diabetic retinopathy in individuals with impaired glucose tolerance, finding no significant differences in outcomes between intervention and control groups.
Interventions
Exercise therapy
Outcomes
Diabetic retinopathy incidenceHbA1cIncidence of edema during follow-up
Added to Dediabetes Aug 28, 2026RCTs
This pilot study evaluated the acT1ve mobile health app for exercise management in young people with Type 1 Diabetes, showing promising quality and engagement scores.
Interventions
acT1ve mobile health app
Outcomes
Engagement score based on uMARS evaluationEsthetics score based on uMARS evaluationFunctionality score of acT1ve+4 more
Added to Dediabetes Aug 28, 2026RCTs
Text message-delivered self-management support improved glycemic control in patients with Type 2 diabetes, particularly in HbA1c levels.
Outcomes
Estimated glomerular filtration rateHbA1cPresence of proteinuria
Added to Dediabetes Aug 24, 2026RCTs
This study compared the efficacy and safety of polyethylene glycol loxenatide (PEG-Loxe) and dapagliflozin in patients with mild-to-moderate diabetic kidney disease, finding both treatments effective in reducing urinary albumin-to-creatinine ratio.
Interventions
DapagliflozinPEG-Loxe 300 µg/week
Outcomes
Diastolic blood pressureHbA1cSystolic blood pressure+2 more
Added to Dediabetes Aug 24, 2026RCTs
The study evaluated Awiqli™ (insulin icodec-abae) for type 2 diabetes, finding significant improvements in glycemic control compared to standard insulins.
Interventions
Insulin icodec (Awiqli)
Outcomes
Improvement in glycemic control for newly diagnosed patientsInjection-site adverse reactions
Added to Dediabetes Aug 22, 2026RCTs
Comparison of qualitative meal-size estimation with carbohydrate counting in adults with type 1 diabetes.
Interventions
Hybrid closed-loop system
Outcomes
Daily units of automated basal insulin deliveredTime in range
Added to Dediabetes Aug 22, 2026RCTs
This study examined the metabolomic signatures associated with the biochemical resolution of Type 2 diabetes following medical therapy or bariatric surgery.
Interventions
Gastric bypassSleeve gastrectomyWeChat-delivered medical nutrition therapy (WeMNT)
Outcomes
BMIDiabetes medication use changeFasting Plasma Glucose (FPG)+1 more
Added to Dediabetes Aug 22, 2026RCTs
This study compared the effects of a Very Low-Carbohydrate Ketogenic Diet (LCK) and a Moderate-Carbohydrate, Calorie-Restricted Low-Fat Diet (MCCR) on individuals with type 2 diabetes or prediabetes.
Interventions
Low-carbohydrate diet
Outcomes
Body weightDiabetes medication use changeHbA1c
